Recombinant B7-H4 (Alsevalimab Biosimilar) antibody
-
- Target See all B7-H4 (Alsevalimab Biosimilar) products
- B7-H4 (Alsevalimab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This B7-H4 (Alsevalimab Biosimilar) antibody is un-conjugated
- Application
- Please inquire
- Purpose
- Research Grade Alsevalimab Biosimilar Antibody
- Specificity
- V-set domain-containing T-cell activation inhibitor 1, B7h.5, B7 homolog 4, B7-H4, T-cell costimulatory molecule B7x, B7H4, VTCN1, Protein B7S1, Immune costimulatory protein B7-H4
- Purification
- Protein A or G purified from cell culture supernatant.
- Purity
- >95 % by SDS-PAGE.
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- 0.01M PBS, pH 7.4.
- Storage
- 4 °C,-20 °C,-80 °C
- Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
- Expiry Date
- 12 months
-
- Target
- B7-H4 (Alsevalimab Biosimilar)
- Alternative Name
- Alsevalimab Biosimilar (B7-H4 (Alsevalimab Biosimilar) Products)
- Target Type
- Biosimilar
- Background
- V-set domain-containing T-cell activation inhibitor 1, B7h.5, B7 homolog 4, B7-H4, T-cell costimulatory molecule B7x, B7H4, VTCN1, Protein B7S1, Immune costimulatory protein B7-H4
- UniProt
- Q7Z7D3
- CAS-No
- 2254029-91-7
-